GB1211   Click here for help

GtoPdb Ligand ID: 11202

Synonyms: compound 11d [Zetterberg et al., 2022] | Example 44 [WO2016120403A1] | GB-1211
Compound class: Synthetic organic
Comment: GB1211 is an orally active small molecule galectin-3 inhibitor [1,5]. It was developed by Galecto Biotech for the treatment of fibrotic disease and cancer. In the fibrotic setting, blocking galectin-3's biological function is predicted to combat the enhanced TGF-β receptor-mediated macrophage differentiation and myofibroblast activation that drives pathological fibrotic changes [2-4].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 5
Topological polar surface area 138.82
Molecular weight 532
XLogP 2.16
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCC1OC(Sc2cncc(c2)Br)C(C(C1O)n1nnc(c1)c1cc(F)c(c(c1)F)F)O
Isomeric SMILES OCC1OC(Sc2cncc(c2)Br)C(C(C1O)n1nnc(c1)c1cc(F)c(c(c1)F)F)O
InChI InChI=1S/C19H16BrF3N4O4S/c20-9-3-10(5-24-4-9)32-19-18(30)16(17(29)14(7-28)31-19)27-6-13(25-26-27)8-1-11(21)15(23)12(22)2-8/h1-6,14,16-19,28-30H,7H2
InChI Key FNCLKJPMEFPXOR-UHFFFAOYSA-N
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
galectin-3 Hs Inhibitor Binding 7.6 pKd - 1
pKd 7.6 (Kd 2.3x10-8 M) [1]